Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Factors Determining Progression to Lower Respiratory Tract Disease | Zendy

YaeJean Kim | Zendy; Katherine A. Guthrie | Zendy; Alpana Waghmare | Zendy; Edward E. Walsh | Zendy; Ann R. Falsey | Zendy; Jane Kuypers | Zendy; Anne Cent | Zendy; Janet A. Englund | Zendy; Michael Boeckh | Zendy

Open Access

Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Factors Determining Progression to Lower Respiratory Tract Disease

Author(s) -

YaeJean Kim,

Katherine A. Guthrie,

Alpana Waghmare,

Edward E. Walsh,

Ann R. Falsey,

Jane Kuypers,

Anne Cent,

Janet A. Englund,

Michael Boeckh

Publication year - 2013

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1093/infdis/jit832

Subject(s) - immunology , medicine , respiratory tract infections , respiratory tract , hematopoietic stem cell transplantation , lower respiratory tract infection , respiratory system , disease

Respiratory syncytial virus (RSV) lower respiratory tract disease (LRD) is a life-threatening complication in hematopoietic cell transplant (HCT) recipients. Lymphopenia has been associated with an increased risk of progression from upper respiratory tract infection (URI) to LRD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research